Literature DB >> 11840465

How frequently and how soon should we screen our patients for the presence of antimalarial retinopathy?

Graciela S Alarcón1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11840465     DOI： 10.1002/art.10054

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  3 in total

1.  Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.

Authors:  Susann Missner; Ulrich Kellner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-04       Impact factor: 3.117

2.  Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L).

Authors:  Graciela S Alarcón; Gerald McGwin; Ana M Bertoli; Barri J Fessler; Jaime Calvo-Alén; Holly M Bastian; Luis M Vilá; John D Reveille
Journal:  Ann Rheum Dis       Date:  2007-03-27       Impact factor: 19.103

3.  Detection of Hydroxychloroquine Retinal Toxicity by Automated Perimetry in 60 Rheumatoid Arthritis Patients with Normal Fundoscopic Findings.

Authors:  Qader Motarjemizadeh; Naser Samadi Aidenloo; Mohammad Abbaszadeh
Journal:  Glob J Health Sci       Date:  2015-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.